Clinical Trial Update: First Time in Human Study With GSK1325756 [Phase 1]

View source ↗

Summary

First-time-in-human Phase 1 study of the investigational compound GSK1325756 by GlaxoSmithKline in chronic obstructive pulmonary disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• GSK1325756

Snippet

Sponsor: GlaxoSmithKline | Conditions: Pulmonary Disease, Chronic Obstructive | Phase 1 | Status: COMPLETED